2015-2016
Q4 January - March, 2016
Q3 October - December, 2015
Q2 July - September, 2015
Q1 April - June, 2015
2014-2015
Q4 January - March, 2015
Q3 October - December, 2014
Q2 July - September, 2014
Q1 April - June, 2014
2013-2014
Q4 January - March, 2014
Q3 October - December, 2013
Q2 July - September, 2013
Q1 April - June, 2013
2012-2013
Q4 January - March, 2013
Q3 October - December, 2012
Q2 July - September, 2012
Q1 April - June, 2012
2011-2012
Q4 January - March, 2012
Q2 July - September, 2011
Q1 April - June, 2011
2010-2011
Q4 January - March, 2011
- Press Release USFDA Final Approval Metolazone Tablets USP 2.5 mg, 5 mg & 10 mg, Dec., 2020
- Press Release Rhizen USFDA Acceptance IND Application SARS-CoV-2 Infection, Dec., 2020
- Press Release Aleor USFDA Tentative Approval Testosterone Gel, 1.62%, November, 2020
- Press Release USFDA Tentative Approval Palbociclib Capsules, 75 mg, 100 mg, and 125 mg, Nov., 2020
- Press Release Sept., 2020
- Press Release Aleor USFDA Final Approval Tavaborole Topical Solution, 5% October, 2020
- Press Release USFDA Approval Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, October, 2020
- Press Release USFDA Approval Amantadine Hydrochloride Tablets, 100 mg October, 2020
- Press Release Rhizen ELA Tenalisib, October, 2020
- Press Release USFDA Tentative Approval Treprostinil Injection, September, 2020
- Press Release USFDA Tentative Approval Empagliflozin and Linagliptin Tablets, August, 2020
- Press Release Aleor USFDA Final Approval Desonide Lotion, 0.05% August, 2020
- Press Release Aleor USFDA Tentative Approval for Tavaborole Topical Solution, 5% August, 2020
- Press Release USFDA Approval Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base), August, 2020
- Press Release June, 2020
- Press Release USFDA Tentative Approval Empagliflozin Metformin Hydrochloride Tablets, July, 2020
- Press Release USFDA Approval Doxycycline Hyclate Tablets USP 75 mg & 150 mg, July, 2020
- Press Release USFDA Tentative Approval Rivaroxaban Tablets, June, 2020
- Press Release Aleor USFDA Final Approval Adapalene Gel USP, 0.3% June, 2020
- Press Release USFDA Approval Deferasirox Tablets 180 mg, June, 2020
- Press Release Aleor USFDA Approval Clobetasol Propionate Shampoo, 0.05% May, 2020
- Press Release USFDA Approval Doxycycline Hyclate Tablets USP 100 mg, May 2020
- Press Release UFR, March 2020
- Press Release USFDA Tentative Approval for Alcaftadine Ophthalmic Solution, April 2020
- Press Release COVID 19 Pandemic, April 2020
- Press Release USFDA Approval Doxycycline Hyclate Tablets USP 20 mg, March. 2020
- Press Release Aleor USFDA Approval Clobetasol Propionate Cream, 0.05% Jan. 2020
- Press Release USFDA Approval Azithromycin Tablets USP 250 mg & 500 mg, Jan. 2020
- Press Release USFDA Approval Azithromycin Tablets USP, Jan. 2020
- Press Release USFDA Approval Bosentan Tablets, Jan. 2020
- Press Release December, 2019
- Press Release USFDA Approval Vilazodone Hydrochloride Tablets, Jan. 2020
- Press Release USFDA Approval Travoprost Ophthalmic Solution USP, 0.004%, December, 2019
- Press Release Aleor USFDA Tentative Approval Diclofenac Sodium December, 2019
- Press Release USFDA Approval Silodosin Capsules 4 mg and 8 mg November, 2019
- Press Release USFDA Approvals Deferasirox Tablets November, 2019
- Press Release September, 2019
- Press Release Aleor USFDA Approval Desonide Ointment, 0.05% October, 2019
- Press Release Aleor USFDA Approval Clobetasol Propionate Topical Solution, 0.05% October, 2019
- Press Release Aleor USFDA Approval Clobetasol Propionate Spray, 0.05% October, 2019
- USFDA Inspection at Bioequivalence Facility August, 2019
- Press Release USFDA Approval Fenofibrate Tablets USP, 48 mg and 145 mg August, 2019
- Press Release USFDA Approval Dorzolamide Hydrochloride Ophthalmic Solution USP August, 2019
- Press Release June, 2019
- Press Release USFDA Tentative Approval Dapagliflozin Tablets July, 2019
- Press Release USFDA Approval Pregabalin Capsules July, 2019
- Press Release USFDA Approval Febuxostat Tablets July, 2019
- Press Release Clonazepam Orally Disintegrating Tablets USP July, 2019
- Press Release Oseltamivir Phosphate Capsules June, 2019
- Press Release USFDA Bromfenac Ophthalmic Solution 0.09% June, 2019
- Press Release USFDA Approval Carbidopa Levodopa ER Tab June, 2019
- Press Release USFDA Approval Solifenacin Succinate Tablets May, 2019
- Press Release March, 2019
- Press Release JVA Chinese Market May, 2019
- Press Release USFDA Approval Olopatadine Hydrochloride Ophthalmic Solution May, 2019
- Press Release USFDA Approval Teriflunomide Tablets April, 2019
- Press Release USFDA Approval Tobramycin Ophthalmic Solution April, 2019
- Press Release USFDA Approval Bimatoprost Ophthalmic Solution, 0.03% April, 2019
- Press Release USFDA Approval Tadalafil Tablets USP March, 2019
- Press Release USFDA Approval Azelastine Hydrochloride Ophthalmic Solution, 0,05% March, 2019
- Press Release Aleor USFDA Approval Clobetasol Propionate Ointment USP, 0.05% March, 2019
- Press Release USFDA Approval Acetazolamide Extended-Release Capsules, 500 mg, February, 2019
- Press Release USFDA Approval Moxifloxacin Ophthalmic Solution USP 0.5%, February, 2019
- Press Release Orit USFDA Approval for Fenofibrate Tablets USP February, 2019
- Press Release December, 2018
- Press Release USFDA Approval Pramipexole Dihydrochloride Extended Release Tablets Jan., 2019
- USFDA Inspection API Facility at Panelav Dec- 2018
- Press Release USFDA Approval Olopatadine Hydrochloride Ophthalmic Solution USP-0.1% Dec, 2018
- Press Release USFDA Approval Candesartan Cilexetil Tablets USP 4mg 8mg 16mg. Dec,2018
- Press Release Orit USFDA Approval Glycopyrrolate Tablets USP 1mg 2mg. Dec,2018
- Press Release USFDA Approval Temazepam Capsules USP 7.5mg 15mg 22.5mg 40mg. Nov,2018
- Press Release Aleor USFDA Approval Lidocaine Ointment USP 5% NOV, 2018
- Press Release USFDA Approval Vardenafil Hydrochloride Orally Disintegrating Tablets 10 mg Nov., 2018
- Press Release September, 2018
- Press Release Successful USFDA Inspection at Aleor Dermaceuticals Limited, October 2018
- Press Release USFDA Tentative Approval Alogliptin Tablets October, 2018
- Press Release USFDA Approval Desvenlafaxine Extended-Release Tablets September,2018
- Press Release USFDA Approval Desvenlafaxine Extended-Release Tablets September, 2018
- Press Release USFDA Tentative Approval Alogliptin & Metformin Tablets September, 2018
- Press Release USFDA Tentative Approval Bimatoprost Ophthalmic Solution, 0.03% August, 2018
- Press Release June, 2018
- Press Release USFDA Tentative Approval Ticagrelor Tablets 90mg July, 2018
- Press Release USFDA Tentative Approval Iloperidone Tablets July, 2018
- Press Release USFDA Approval Doxycycline Hyclate Capsules USP, 50mg and 100mg June, 2018
- Press Release USFDA Approval Bupropion Hydrochloride Tablets USP, 75 mg and 100 mg June, 2018
- USFDA Inspection API Facility at Karkhadi May, 2018
- Q4 Net revenue grew 15% to Rs 853 Crores, Net profit at Rs 93 Crores May, 2018
- USFDA Inspection API Facility at Panelav April, 2018
- Press Release USFDA Approval Acyclovir ointment USP, 5% April, 2018
- USFDA Inspection Formulation Facility at Panelav March, 2018
- Press Release December, 2017
- Press Release Rhizen receives FDA Orphan-Drug Designation for Tenalisib (RP6530) December, 2017
- Press Release USFDA Approval Darifenacin Extended Release Tablets December, 2017
- Press Release Rhizen receives FDA Fast Track Designation for RP6530 (tenalisib) December, 2017
- Press Release September, 2017
- Press Release Acquisition of US based generic drug developer Orit Laboratories LLC Nov, 2017
- Press Release USFDA Approval Doxycycline Capsules USP July, 2017
- Press Release April June, 2017
- Press Release USFDA Approval Olmesartan Medoxomil & Amlodipine Tablets July,2017
- Press Release Inauguration Anti-Cancer Manufacturing Facilty at Panelav, Halol July,2017
- Press Release USFDA Tentative Approval Dabigatran Etexilate Capsules July,2017
- Press Release USFDA Tentative Approval Vardenafil Hydrochloride Orally Disintegrating Tablets July,2017
- Press Release USFDA Approval Amantadine Hydrochloride Capsules USP June,2017
- Press Release USFDA Approval Candesartan Cilexetil Tablets June,2017
- Press Release USFDA Approval Fenofibric Acid Delayed-Release Capsules May, 2017
- Press Release January March, 2017
- Press Release USFDA Approval Olmesartan Medoxomil Tablets & Olmesartan Medoxomil with Hydrochlorothiazide Tablets April, 2017
- Press Release USFDA Tentative Approval Vilazodone Tablets April, 2017
- Press Release Successful USFDA Inspection Bioequivalence April, 2017
- Press Release USFDA Approval Fluoxetine Hydrochloride Tablets April, 2017
- Press Release Successful USFDA Inspection Bioequivalence March, 2017
- Press Release Launch Desvenlafaxine Succinate Extended Release Tablets March, 2017
- Press Release October December, 2016
- Press Release USFDA Approval Itraconazole Capsules December, 2016
- Press Release Approval Telmisartan Amlodipine November, 2016
- Press Release USFDA Approval Zolmitriptan Orally Disintergrating Tablets November, 2016
- Press Release July - September, 2016
- Press Release April - June, 2016
- Press Release USFDA Tentative Approval Febuxostat July, 2016
- Press Release - JVA - 2016
- Press Release - USFDA Approval - Lacosamide - 2016
- Press Release - January - March, 2016
- Press Release - October - December, 2015
- Press Release - July - September, 2015
- Press Release - April - June, 2015
- Press Release - January - March, 2015
- Press Release - October - December, 2014
- Press Release - July - September, 2014
- Press Release - April - June, 2014
- Press Release - January - March, 2014
- Press Release - October - December, 2013
- Press Release - July - September, 2013
- Press Release - April - June, 2013
- Press Release - January - March, 2013
- Press Release - October - December, 2012
- Press Release - July - September, 2012
- Press Release - April - June, 2012
- Press Release - January - March, 2012
- Press Release - July - September, 2011
- Press Release - April - June, 2011
- Press Release - March, 2011